Butcher Arthur C 4

4 · BOSTON SCIENTIFIC CORP · Filed Feb 17, 2026

AI-generated summary of this filing

Updated Feb 18, 2026

Boston Scientific (BSX) EVP Arthur Butcher Exercises Options, Receives Awards

What Happened

Arthur C. Butcher, EVP & Group President, MedSurg & APAC at Boston Scientific (BSX), had multiple equity transactions reported for Feb 12, 2026. He converted/exercised 2,692 derivative units into shares and received two awards totaling 50,995 restricted stock units (RSUs) (15,178 and 35,817). To satisfy tax withholding related to these transactions, 1,302 shares were withheld/disposed at $74.12 per share, totaling $96,504. The reported exercises/grants show $0.00 per-share amounts for the conversion/grants (typical for RSU settlement entries).

Key Details

Transaction date: February 12, 2026 (all reported transactions).
Exercise/conversion: 2,692 derivative units converted to shares (transaction code M).
Tax withholding: 1,302 shares withheld/paid (transaction code F) at $74.12 → $96,504 withheld.
Grants/awards: 15,178 RSUs and 35,817 RSUs granted (transaction code A), total 50,995 RSUs.
Shares owned after transaction: Not specified in the provided filing excerpt.
Relevant footnotes from the filing:
- F1: Each RSU equals one share of Boston Scientific common stock.
- F2: Balance information reflects 401(k) plan holdings where applicable.
- F3: One award’s shares to be issued in four equal annual installments beginning Feb 12, 2025.
- F4: The other award’s shares to be issued in four equal annual installments beginning Feb 12, 2027.
- F5: Option grant referenced vests in four equal annual installments beginning Feb 12, 2027.
Filing timeliness: Not specified in the provided data.

Context

The filing shows awards of RSUs and a conversion/exercise of derivatives rather than an open-market buy or sale. The 1,302-share disposal was a tax-withholding event (common when RSUs vest or options are exercised) — not an open-market sale reflecting a change in investment view. The RSU grants come with vesting/issuance schedules (see F3–F5), and the option referenced vests over multiple years.

Form 4

Period: 2026-02-12

EVP& Grp Pres, MedSurg & APAC

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-02-12+2,692→ 26,292 total
Tax Payment
Common Stock
2026-02-12$74.12/sh−1,302$96,504→ 24,990 total
Exercise/Conversion
Restricted Stock Units
[F1][F3]
2026-02-12−2,692→ 5,386 total
Exp: 2028-02-12→ Common Stock (2,692 underlying)
Award
Restricted Stock Units
[F1][F4]
2026-02-12+15,178→ 15,178 total
Exp: 2030-02-12→ Common Stock (15,178 underlying)
Award
Stock Option (Right to Buy)
[F5]
2026-02-12+35,817→ 35,817 total
Exercise: $74.12Exp: 2036-02-12→ Common Stock (35,817 underlying)

Holdings

Footnotes (5)

[F1]Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
[F2]Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
[F3]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.
[F4]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.
[F5]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.

Signature

/s/ Susan Thompson, Attorney-in-Fact|2026-02-17

1 file